Cancer immunoediting: from immunosurveillance to tumor escape
- PMID: 12407406
- DOI: 10.1038/ni1102-991
Cancer immunoediting: from immunosurveillance to tumor escape
Abstract
The concept that the immune system can recognize and destroy nascent transformed cells was originally embodied in the cancer immunosurveillance hypothesis of Burnet and Thomas. This hypothesis was abandoned shortly afterwards because of the absence of strong experimental evidence supporting the concept. New data, however, clearly show the existence of cancer immunosurveillance and also indicate that it may function as a component of a more general process of cancer immunoediting. This process is responsible for both eliminating tumors and sculpting the immunogenic phenotypes of tumors that eventually form in immunocompetent hosts. In this review, we will summarize the historical and experimental basis of cancer immunoediting and discuss its dual roles in promoting host protection against cancer and facilitating tumor escape from immune destruction.
Comment in
-
Observing the invisible: successful tumor immunity in humans.Nat Immunol. 2003 Mar;4(3):201. doi: 10.1038/ni0303-201. Nat Immunol. 2003. PMID: 12605223 No abstract available.
-
A cancer immunosurveillance controversy.Nat Immunol. 2004 Jan;5(1):3-4; author reply 4-5. doi: 10.1038/ni0104-3. Nat Immunol. 2004. PMID: 14699396 No abstract available.
-
Halo naevus: a visible case of immunosurveillance in humans?Lancet Oncol. 2004 Jul;5(7):397-8. doi: 10.1016/S1470-2045(04)01505-0. Lancet Oncol. 2004. PMID: 15231244 No abstract available.
Similar articles
-
The immunobiology of cancer immunosurveillance and immunoediting.Immunity. 2004 Aug;21(2):137-48. doi: 10.1016/j.immuni.2004.07.017. Immunity. 2004. PMID: 15308095 Review.
-
Tumor immunoediting and immunosculpting pathways to cancer progression.Semin Cancer Biol. 2007 Aug;17(4):275-87. doi: 10.1016/j.semcancer.2007.06.009. Epub 2007 Jun 26. Semin Cancer Biol. 2007. PMID: 17662614 Free PMC article. Review.
-
Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.Ann N Y Acad Sci. 2013 May;1284(1):1-5. doi: 10.1111/nyas.12105. Ann N Y Acad Sci. 2013. PMID: 23651186 Free PMC article.
-
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.Science. 2011 Mar 25;331(6024):1565-70. doi: 10.1126/science.1203486. Science. 2011. PMID: 21436444 Review.
-
The three Es of cancer immunoediting.Annu Rev Immunol. 2004;22:329-60. doi: 10.1146/annurev.immunol.22.012703.104803. Annu Rev Immunol. 2004. PMID: 15032581 Review.
Cited by
-
Comparing the ability of freshly generated and cryopreserved dendritic cell vaccines to inhibit growth of breast cancer in a mouse model.Biores Open Access. 2012 Oct;1(5):239-46. doi: 10.1089/biores.2012.0229. Biores Open Access. 2012. PMID: 23515111 Free PMC article.
-
Prognostic value of antitumor drug targets prediction using integrated bioinformatic analysis for immunogenic cell death-related lncRNA model based on stomach adenocarcinoma characteristics and tumor immune microenvironment.Front Pharmacol. 2022 Oct 14;13:1022294. doi: 10.3389/fphar.2022.1022294. eCollection 2022. Front Pharmacol. 2022. PMID: 36313374 Free PMC article.
-
Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies.J Clin Med. 2021 Apr 1;10(7):1455. doi: 10.3390/jcm10071455. J Clin Med. 2021. PMID: 33916320 Free PMC article. Review.
-
Loss of LXN promotes macrophage M2 polarization and PD-L2 expression contributing cancer immune-escape in mice.Cell Death Discov. 2022 Nov 3;8(1):440. doi: 10.1038/s41420-022-01227-7. Cell Death Discov. 2022. PMID: 36323670 Free PMC article.
-
Current and emerging therapies in unresectable and recurrent gastric cancer.World J Gastroenterol. 2016 May 28;22(20):4812-23. doi: 10.3748/wjg.v22.i20.4812. World J Gastroenterol. 2016. PMID: 27239108 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases